BRISTOL-MYERS SQUIBB COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.26 USD | +1.87% |
|
+1.19% | -17.63% |
| 01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
| Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 84.08B | - | |||||
| 765B | ||||||
| 354B | - | - | - | - | ||
| 331B | ||||||
| 299B | ||||||
| 248B |
